Diversified Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Sell |
613
-19
| -3% | -$8.46K | 0.01% | 780 |
|
|
2025
Q1 | $306K | Buy |
632
+95
| +18% | +$46.1K | 0.01% | 724 |
|
|
2024
Q4 | $216K | Sell |
537
-491
| -48% | -$198K | 0.01% | 831 |
|
|
2024
Q3 | $479K | Sell |
1,028
-522
| -34% | -$243K | 0.01% | 597 |
|
|
2024
Q2 | $727K | Buy |
1,550
+95
| +7% | +$44.6K | 0.02% | 430 |
|
|
2024
Q1 | $608K | Sell |
1,455
-493
| -25% | -$206K | 0.02% | 461 |
|
|
2023
Q4 | $793K | Buy |
1,948
+17
| +0.9% | +$6.92K | 0.03% | 358 |
|
|
2023
Q3 | $671K | Sell |
1,931
-454
| -19% | -$158K | 0.03% | 363 |
|
|
2023
Q2 | $839K | Buy |
2,385
+786
| +49% | +$277K | 0.03% | 323 |
|
|
2023
Q1 | $504K | Sell |
1,599
-721
| -31% | -$227K | 0.02% | 458 |
|
|
2022
Q4 | $670K | Buy |
2,320
+553
| +31% | +$160K | 0.03% | 348 |
|
|
2022
Q3 | $512K | Buy |
1,767
+497
| +39% | +$144K | 0.02% | 383 |
|
|
2022
Q2 | $358K | Sell |
1,270
-1,395
| -52% | -$393K | 0.02% | 513 |
|
|
2022
Q1 | $695K | Buy |
2,665
+46
| +2% | +$12K | 0.02% | 347 |
|
|
2021
Q4 | $575K | Sell |
2,619
-535
| -17% | -$117K | 0.02% | 410 |
|
|
2021
Q3 | $572K | Sell |
3,154
-489
| -13% | -$88.7K | 0.02% | 361 |
|
|
2021
Q2 | $735K | Buy |
3,643
+337
| +10% | +$68K | 0.03% | 297 |
|
|
2021
Q1 | $710K | Buy |
3,306
+107
| +3% | +$23K | 0.03% | 279 |
|
|
2020
Q4 | $756K | Hold |
3,199
| – | – | 0.03% | 254 |
|
|
2020
Q3 | $871K | Buy |
3,199
+1,232
| +63% | +$335K | 0.04% | 207 |
|
|
2020
Q2 | $571K | Buy |
1,967
+330
| +20% | +$95.8K | 0.03% | 238 |
|
|
2020
Q1 | $390K | Buy |
1,637
+11
| +0.7% | +$2.62K | 0.02% | 253 |
|
|
2019
Q4 | $356K | Buy |
+1,626
| New | +$356K | 0.02% | 304 |
|